From the analysis of clinical information in conjunction with IL-17A or IL-17F gene polymorphisms, we found that the IL-17A and IL-17F genes may influence the diagnosis, treatment, and prognosis of breast cancer. The gene discussed is IL17F; the disease is breast carcinoma.